strontium/sarcoma

Lyen an sove nan clipboard la

AtikEsè klinikPatant

Chwazi kalite sòt

15 rezilta yo

Strontium-90 for conjunctival AIDS-related Kaposi's sarcoma: the first case report.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

AIDS-related Kaposi's sarcoma is often treated by local therapy for physically or cosmetically disabling symptoms. We present the first case of a bulbar conjunctival Kaposi's sarcoma lesion to be treated with a strontium-90 ophthalmic applicator. The treatment is simple, effective and well tolerated

[Value of the study of the kinetics of 85 strontium for the classification of osteogenic sarcomas ].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Because of the polymorphism of osteogenic sarcomas, examination of a biopsy specimen, which is necessarily small, cannot give an accurate evaluation of the differentiation of the whole tumor. Therefore, a test which provides an overall assessment of the functional capacity of the tumor is needed.

Bone sarcoma characteristics and distribution in beagles fed strontium-90.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A total of 66 primary bone sarcomas were diagnosed in 47 beagles; 43 of these dogs were part of the 403 beagles fed 90Sr and 4 were part of the 162 controls. Multiple primary bone sarcomas were found in 15 of the 47 beagles (32%). The incidence of multiple primary bone sarcoma was restricted to the

Vasoformative non-osteogenic (angio) sarcomas of bone-marrow stroma due to strontium-90.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

In a series of experiments, mainly CBA/H, but also C2H/H, mice aged 3 months were injected intraperitoneally with solutions of 90Sr Cl2, the dose per mouse varying from 7 to 20 muCi, and compared with similar mice treated with 226Ra or 239Pu, discussed elsewhere. In male mice, the commonest tumour

[Osteogenic sarcoma induced by strontium(90) in dogs].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

[The pathogenesis of bone sarcomas in rats following administration of strontium 89 and the effect of strontium 89 on the progeny of these animals].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Strontium-90 in the long bones of patients with sarcoma.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

[X-ray morphological study of development of bone sarcoma in animals poisoned with radioactive strontium].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

[Effect of roentgen irradiation on the growth, microscopic and submicroscopic structure of bone sarcoma induced with radioactive strontium].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Strontium promotes osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Strontium ralenate is a new anti-osteoporosis agent. The cellular and molecular mechanism underlying the anabolic effect of strontium on bone remains to be elucidated. Osteoblasts, the main bone forming cells are known to be derived from bone marrow mesenchymal stem cells (MSCs). The present study

Strontium-89 therapy: strontium kinetics and dosimetry in two patients treated for metastasising osteosarcoma.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

We report a study of strontium kinetics in two patients who received 89Sr therapy for disseminated osteogenic sarcoma, together with estimates of absorbed dose to the principal metastases and to bone marrow. In neither patient did tumour uptake of strontium have a significant effect on whole-body

Radiation-induced meningeal and pituitary tumors in the rat after prenatal application of strontium-90.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Strontium-90 was inject i.v. into pregnant rats on day 18 post conception (p.c.). This caused a remarkable transplacental radioactivity uptake and accumulation in the ossification centers of the skull basis. The total radiation dose within the surface of these regions was consequently calculated to

Human osteogenic sarcoma: fine structural localization of adenosine triphosphatase.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The localization of ATPases in 7 osteogenic sarcomas of osteoblastic, chondroblastic and fibroblastic type was investigated at the fine structural level using two types of substrates: one with lead as capturing ion and one with strontium (the latter presumed to reveal sites of Na+-K+-dependent

[Comparative data from radioisotopic and x-ray methods of study in osteogenic group tumors].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A comparative analysis of the data of roentgenography-angiography, scanning and radiometry with strontium-85 in 54 patients showing osteogenic sarcoma and osteoblastoclastoma has demonstrated a relationship between the quantitative characteristics of the radioactive Sr inclusion and the intensity of

Safety of drugs used in the treatment of osteoporosis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A number of drug classes are licensed for the treatment of osteoporosis including bisphosphonates, recombinant human parathyroid hormone (PTH), strontium, hormone replacement therapy (HRT), selective oestrogen receptor modulators (SERMS) and denosumab. This review discusses the safety of

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye